Drugs / BEN8744
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06118385 | Aug 2023 → Mar 2024 | — | BenevolentAI Bio | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BEN8744 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06118385 ↗ |
| Route | Oral | “Formulated powder in capsule for oral administration” NCT06118385 ↗ |